425
Views
27
CrossRef citations to date
0
Altmetric
Infammatory Bowel Disease

Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease

, , , , , & show all
Pages 1181-1191 | Received 03 Jan 2012, Accepted 15 Feb 2012, Published online: 31 Jul 2012

References

  • Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38–45.
  • Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665–72.
  • Assche GA, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohn's Colitis 2010;4:63–101.
  • Henckaerts L, Van Steen K, Verstreken I, Cleynen I, Franke A, Schreiber S, Genetic risk profiling and prediction of disease course in Crohn's disease patients. Clin Gastroenterol Hepatol 2009;7:972–80.
  • Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009;104:371–83.
  • Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001;7:306–13.
  • Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008;23:1213–21.
  • Simillis C, Yamamoto T, Reese GE, Umegae S, Matsumoto K, Darzi AW, A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol 2008;103:196–205.
  • Regueiro M, Schraut W, Baidoo L, Kip K, Sepulveda A, Pesci M, Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection. Gastroenterology 2009;136:441-450.
  • Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6.
  • Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–53.
  • Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M, Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956–63.
  • Dombal FT, Burton I, Goligher JC. Recurrence of Crohn's disease after primary excisional surgery. Gut 1971;12:519–27.
  • Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665–72.
  • Figg RE, Church JM. Perineal Crohn's disease: an indicator of poor prognosis and potential proctectomy. Dis Colon Rectum 2009;52:646–50.
  • Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 2008;135:1442–7.
  • Frøslie KF, Jahnsen J, Moum BA, Vatn MH; IBSEN Group. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–22.
  • Chow DKL, Leong RWL, Lai LH, Wong GL, Leung WK, Chan FK, Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis 2008;14:536–41.
  • Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol 2009;15:3504–10.
  • Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895–902.
  • Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237–41.
  • Thia KT, Luman W, Jin OC. Crohn's disease runs a more aggressive course in young Asian patients. Inflamm Bowel Dis 2006;12:57–61.
  • Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, Clinical course and long-term prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003;38:942–53.
  • Assche GA, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De vos M, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohn's Colitis 2010;4:63–101.
  • Figg RE, Church JM. Perineal Crohn's disease: An indicator of poor prognosis and potential proctectomy. Dis Colon Rectum 2009;52:646–50.
  • Greenstein AJ, Lachman P, Sachar DB, Perforating and nonperforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.